Metropolis Healthcare Limited (NSE:METROPOLIS)

Market Cap	101.04B
Revenue (ttm)	13.31B
Net Income (ttm)	1.45B
Shares Out	51.81M
EPS (ttm)	28.15
PE Ratio	69.28
Forward PE	50.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	77,459
Average Volume	305,975
Open	1,950.00
Previous Close	1,950.30
Day's Range	1,945.50 - 2,034.90
52-Week Range	1,315.00 - 2,318.30
Beta	0.16
RSI	63.31
Earnings Date	Aug 4, 2025

About Metropolis Healthcare

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provid...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1980
• Employees: 4,823
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: METROPOLIS

Financial Performance

In 2024, Metropolis Healthcare's revenue was 13.31 billion, an increase of 10.23% compared to the previous year's 12.08 billion. Earnings were 1.45 billion, an increase of 13.42%.